Rackemann, F.M., A working classification of asthma. Am J Med 3 (1947), 601–606.
Brusselle, G.G., Maes, T., Bracke, K.R., Eosinophils in the spotlight: eosinophilic airway inflammation in nonallergic asthma. Nat Med 19 (2013), 977–979.
Quaedvlieg, V., Sele, J., Henket, M., Louis, R., Association between asthma control and bronchial hyperresponsiveness and airways inflammation: a cross-sectional study in daily practice. Clin Exp Allergy 39 (2009), 1822–1829.
Schleich, F.N., Chevremont, A., Paulus, V., Henket, M., Manise, M., Seidel, L., et al. Importance of concomitant local and systemic eosinophilia in uncontrolled asthma. Eur Respir J 44 (2014), 97–108.
Walsh, C.J., Zaihra, T., Benedetti, A., Fugère, C., Olivenstein, R., Lemière, C., et al. Exacerbation risk in severe asthma is stratified by inflammatory phenotype using longitudinal measures of sputum eosinophils. Clin Exp Allergy 46 (2016), 1291–1302.
Hemelaers, L., Henket, M., Sele, J., Bureau, F., Louis, R., Cysteinyl-leukotrienes contribute to sputum eosinophil chemotactic activity in asthmatics. Allergy 61 (2006), 136–139.
Mouthuy, J., Detry, B., Sohy, C., Pirson, F., Pilette, C., Presence in sputum of functional dust mite–specific IgE antibodies in intrinsic asthma. Am J Respir Crit Care Med 184 (2011), 206–214.
Lambrecht, B.N., Hammad, H., The immunology of asthma. Nat Immunol 16 (2015), 45–56.
Manise, M., Holtappels, G., Van Crombruggen, K., Schleich, F., Bachert, C., Louis, R., Sputum IgE and cytokines in asthma: relationship with sputum cellular profile. PLoS One 8 (2013), 1–9.
Humbert, M., Durham, S.R., Ying, S., Kimmitt, P., Barkans, J., Assoufi, B., et al. IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against “intrinsic” asthma being a distinct immunopathologic entity. Am J Respir Crit Care Med 154 (1996), 1497–1504.
Sunyer, J., Antó, J.M., Castellsagué, J., Soriano, J.B., Roca, J., Total serum IgE is associated with asthma independently of specific IgE levels. Eur Respir J 9 (1996), 1880–1884.
Cruse, G., Kaur, D., Yang, W., Duffy, S.M., Brightling, C.E., Bradding, P., Activation of human lung mast cells by monomeric immunoglobulin E. Eur Respir J 25 (2005), 858–863.
Louis, R., Pilette, C., Michel, O., Michils, A., Brusselle, G., Poskin, A., et al. Variability in total serum IgE over 1 year in severe asthmatics. Allergy Asthma Clin Immunol 15 (2019), 1–9.
van Rijt, L., von Richthofen, H., van Ree, R., Type 2 innate lymphoid cells: at the cross-roads in allergic asthma. Semin Immunopathol 38 (2016), 483–496.
Delvaux, M., Henket, M., Lau, L., Kange, P., Bartsch, P., Djukanovic, R., et al. Nebulised salbutamol administered during sputum induction improves bronchoprotection in patients with asthma. Thorax 59 (2004), 111–115.
Juniper, E.F., Guyatt, G.H., Epstein, R.S., Ferrie, P.J., Jaeschke, R., Hiller, T.K., Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 47 (1992), 76–83.
Juniper, E.F., O'Byrne, P.M., Guyatt, G.H., Ferrie, P.J., King, D.R., Development and validation of a questionnaire to measure asthma control. Eur Respir J 14 (1999), 902–907.
Nathan, R.A., Sorkness, C.A., Kosinski, M., Schatz, M., Li, J.T., Marcus, P., et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 113 (2004), 59–65.
Amelink, M., de Nijs, S.B., de Groot, J.C., van Tilburg, P.M.B., van Spiegel, P.I., Krouwels, F.H., et al. Three phenotypes of adult-onset asthma. Allergy 68 (2013), 674–680.
Ulrik, C.S., Lange, P., Decline of lung function in adults with bronchial asthma. Am J Respir Crit Care Med 150 (1994), 629–634.
Wenzel, S.E., Asthma: defining of the persistent adult phenotypes. Lancet 368 (2006), 804–813.
Manise, M., Schleich, F., Gusbin, N., Godinas, L., Henket, M., Antoine, N., et al. Cytokine production from sputum cells and blood leukocytes in asthmatics according to disease severity. Allergy Eur J Allergy Clin Immunol 65 (2010), 889–896.
Louis, R., Shute, J., Biagi, S., Stanciu, L., Marrelli, F., Tenor, H., et al. Cell infiltration, ICAM-1 expression, and eosinophil chemotactic activity in asthmatic sputum. Am J Respir Crit Care Med 155 (1997), 466–472.
Barnes, P.J., Intrinsic asthma: not so different from allergic asthma but driven by superantigens?. Clin Exp Allergy 39 (2009), 1145–1151.
Domingo, C., Omalizumab for severe asthma: efficacy beyond the atopic patient?. Drugs 74 (2014), 521–533.
Watt, A., Schock, B., Ennis, M., Neutrophils and eosinophils: clinical implications of their appearance, presence and disappearance in asthma and COPD. Curr Drug Target Inflammation Allergy 4 (2005), 415–423.
Kanda, A., Driss, V., Hornez, N., Abdallah, M., Roumier, T., Abboud, G., et al. Eosinophil-derived IFN-γ induces airway hyperresponsiveness and lung inflammation in the absence of lymphocytes. J Allergy Clin Immunol, 124, 2009 [573–582.e9].
Walsh, G.M., Targeting eosinophils in asthma: current and future state of cytokine- and chemokine-directed monoclonal therapy. Expert Rev Clin Immunol 6 (2010), 701–704.
Gibson, P.G., Saltos, N., Borgas, T., Airway mast cells and eosinophils correlate with clinical severity and airway hyperresponsiveness in corticosteroid-treated asthma. J Allergy Clin Immunol 105 (2000), 752–759.
Louis, R., Sele, J., Henket, M., Cataldo, D., Bettiol, J., Seiden, L., et al. Sputum eosinophil count in a large population of patients with mild to moderate steroid-naive asthma: distribution and relationship with methacholine bronchial hyperresponsiveness. Allergy 57 (2002), 907–912.
Sterk, P.J., Fabbri, L.M., Quanjer, P.H., Cockcroft, D.W., O'Byrne, P.M., Anderson, S.D., et al. Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 16 (1993), 53–83.
Meijer, R.J., Kerstjens, H.A., Arends, L.R., Kauffman, H.F., Koëter, G.H., Postma, D.S., Effects of inhaled fluticasone and oral prednisolone on clinical and inflammatory parameters in patients with asthma. Thorax 54 (1999), 894–899.
Ward, C., Pais, M., Bish, R., Reid, D., Feltis, B., Johns, D., et al. Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma. Thorax 57 (2002), 309–316.
Juniper, E.F., Kline, P.A., Vanzieleghem, M.A., Ramsdale, E.H., O'byrne, P.M., Hargreave, F.E., Effect of long-term treatment with an inhaled corticosteroid (Budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis 142 (1990), 832–836.
Coumou, H., Westerhof, G.A., de Nijs, S.B., Amelink, M., Bel, E.H., Diagnosing persistent blood eosinophilia in asthma with single blood eosinophil or exhaled nitric oxide level. Respir Med 141 (2018), 81–86.
van Veen, I.H., ten Brinke, A., Gauw, S.A., Sterk, P.J., Rabe, K.F., Bel, E.H., Consistency of sputum eosinophilia in difficult-to-treat asthma: a 5-year follow-up study. J Allergy Clin Immunol, 124, 2009 [615–617.e2].
Silkoff, P.E., Laviolette, M., Singh, D., FitzGerald, J.M., Kelsen, S., Backer, V., et al. Longitudinal stability of asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) study. Respir Res, 17, 2016, 43.
Barbee, R.A., Halonen, M., Kaltenborn, W., Lebowitz, M., Burrows, B., A longitudinal study of serum IgE in a community cohort: correlations with age, sex, smoking, and atopic status. J Allergy Clin Immunol 79 (1987), 919–927.
Sherrill, D.L., Halonen, M., Burrows, B., Relationships between total serum IgE, atopy, and smoking: a twenty-year follow-up analysis. J Allergy Clin Immunol 94 (1994), 954–962.
